Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial

ONESOURCE SPECIALTY PHARMA LIMITED has recalled Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on July 15, 2026 and was initiated on June 7, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, with approximately 4284 vials affected. The company behind the recall is ONESOURCE SPECIALTY PHARMA LIMITED, based in Bengaluru, N/A. The FDA describes the product as: “Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31”

Why was Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial recalled?

According to the FDA, the stated reason for the recall is: “Failed Impurities/Degradation Specifications.” In plain terms, this recall relates to a chemical impurity.

This recall involves an unwanted chemical detected in the medicine — often a nitrosamine impurity, which regulators limit because long-term exposure above set levels may increase health risks. Regulators recall affected batches as a precaution. Health authorities generally advise talking to a doctor or pharmacist before stopping a prescribed medicine.

What should you do?

If you think you may have bought Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, compare it against the product description and identifying codes (Lot #: 7000612A, Exp. Date 1/2028) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact ONESOURCE SPECIALTY PHARMA LIMITED or your local health authority.

About this recall

This recall was distributed in N/A. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.